Clonal CD4<sup>+</sup> T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29686423.
- Also identified by DOI 10.1038/s41591-018-0017-7 and PMC identifier 5972543.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite suppressive combination antiretroviral therapy (ART), latent HIV-1 proviruses persist in patients. This latent reservoir is established within 48-72 h after infection, has a long half-life<sup>1,2</sup>, enables viral rebound when ART is interrupted, and is the major barrier to a cure for HIV-1 <sup>3</sup> . Latent cells are exceedingly rare in blood (∼1 per 1 × 10<sup>6</sup> CD4<sup>+</sup> T cells) and are typically enumerated by indirect means, such as viral outgrowth assays<sup>4,5</sup>. We report a new strategy to purify and characterize single reactivated latent cells from HIV-1-infected individuals on suppressive ART. Surface expression of viral envelope protein was used to enrich reactivated latent T cells producing HIV RNA, and single-cell analysis was performed to identify intact virus. Reactivated latent cells produce full-length viruses that are identical to those found in viral outgrowth cultures and represent clones of in vivo expanded T cells, as determined by their T cell receptor sequence. Gene-expression analysis revealed that these cells share a transcriptional profile that includes expression of genes implicated in silencing the virus. We conclude that reactivated latent T cells isolated from blood can share a gene-expression program that allows for cell division without activation of the cell death pathways that are normally triggered by HIV-1 replication.
Medical subject headings
- CD4-Positive T-Lymphocytes
- Gene Expression Profiling
- HIV-1
- Virus Latency